An HIV vaccine is the ultimate goal on which research groups are conducting intensive research. In April 2016, the HIV Vaccine Trails Network contacted Dr. Hugo Tempelman. The HIV Vaccine Trials Network is the world’s largest publicly funded, international network of researchers, clinics and laboratories working together towards the ultimate goal of finding a vaccine against HIV.
The second phase of the vaccine study – the human trial – started for the first time at the end of January 2018 at the new Ndlovu Research Center. As part of this study, Ndlovu is treating a total of 169 patients who will be injected with the vaccine over a period of three years. Between 7 and 15 people can be treated each month, as the procedure is highly complex.
The Ndlovu Care Group is one of only two institutions in South Africa able to provide the conditions for this study. Worldwide, 26 research groups are participating in this study.
Read more at:
